BRAF and melanoma: In the clinic, BRAF inhibition has improved metastasis of melanoma, and during treatment, tumors exhibited a significant increase in CD8+ T cells, which is linked to the down regulation of vascular endothelial growth factor (VEGF) and IL-6, IL-1α cytokines.